Orthobiologics Devices And Equipment Market Growth Is Accelerating As Industry Transformation Continues
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
The orthobiologics devices and equipment market has demonstrated significant growth recently, driven by an increasing need for advanced treatments in musculoskeletal health. This sector is poised for continued expansion as technological innovations and demographic shifts contribute to rising demand worldwide. Let’s explore the market’s current size, growth drivers, segmentation, key industry players, and geographic trends shaping its future.
Orthobiologics Devices and Equipment Market Size and Growth Forecast
The market for orthobiologics devices and equipment is on an upward trajectory, projected to grow from $5.99 billion in 2025 to $6.36 billion in 2026, reflecting a compound annual growth rate (CAGR) of 6.2%. This growth is supported by factors such as the rising incidence of musculoskeletal disorders, increased sports injuries, a surge in orthopedic surgeries, wider acceptance of platelet-rich plasma (PRP) therapies, and the clinical success of bone graft applications. Looking ahead, the market is expected to reach $8.64 billion by 2030, growing at a CAGR of 8.0%. This forecasted growth will be fueled by the aging population, advancements in regenerative medicine, demand for minimally invasive procedures, expanded reimbursement policies, and innovations in biomaterials. Important trends anticipated during this period include increased adoption of regenerative therapies, growth in treatments for sports-related injuries, rising use of stem cell-based products, a preference for non-surgical orthopedic options, and the expansion of specialized orthopedic clinics.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2568&type=smp
Primary Factors Propelling Growth in the Orthobiologics Devices and Equipment Market
The growing prevalence of orthopedic conditions is a significant driver behind the market’s expansion. Orthopedic disorders encompass a range of ailments affecting bones, joints, muscles, ligaments, tendons, and nerves, with the aging population being particularly susceptible to issues such as osteoarthritis, osteoporosis, and fractures. Orthobiologics devices and equipment play a crucial role in these treatments by promoting natural tissue regeneration, thereby enhancing bone and joint function restoration. These technologies not only improve healing effectiveness but also shorten patient recovery periods.
For example, a survey conducted in August 2023 by the Institute for Health Metrics and Evaluation in the United States found that 15% of adults aged 30 and above suffered from osteoarthritis in 2023. The number of affected individuals worldwide is projected to approach 1 billion by 2050, highlighting the urgency and scale of demand for orthobiologics solutions.
Segments Offering the Greatest Opportunities in the Orthobiologics Devices and Equipment Market
This market is categorized into several segments to better understand growth areas:
1) Product Type: Demineralized Bone Matrix, Synthetic Bone Substitutes, Stem Cell Therapy, Plasma-Rich Protein, Viscosupplementation, Bone Morphogenetic Protein, Synthetic Orthobiologics
2) Application Areas: Osteoarthritis and Degenerative Arthritis, Soft-Tissue Injuries, Fracture Recovery, Maxillofacial and Dental Applications, Spinal Fusion, Trauma Repair, Reconstructive Surgery
3) End Users: Hospitals, Orthopedic Clinics, Other Users
Access The Complete Orthobiologics Devices And Equipment Market Report:
The product types are further broken down, such as:
– Demineralized Bone Matrix: injectable forms, paste and putty, scaffolds
– Synthetic Bone Substitutes: calcium phosphate ceramics, bioactive glasses, polymers, and composites
– Stem Cell Therapy: adipose-derived, bone marrow-derived, umbilical cord blood-derived products
– Plasma-Rich Protein: platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) products
– Viscosupplementation: hyaluronic acid injections and combination products
– Bone Morphogenetic Protein (BMP): recombinant proteins and delivery systems
– Synthetic Orthobiologics: growth factor-enhanced products, biodegradable scaffolds with bioactive agents, and other synthetic formulations
Recent Trends and Innovations Influencing the Orthobiologics Market
Companies in this market are increasingly focusing on developing cutting-edge regenerative technologies to improve patient outcomes and minimize complications. One such innovation is synthetic bone fusion gels, which serve as both a scaffold and delivery mechanism for growth factors, aiding bone growth in spinal and orthopedic surgeries.
For instance, in January 2024, Renovos Biologics Ltd., a UK biomaterial firm affiliated with Biocomposites, received FDA Breakthrough Device Designation for its synthetic nanoclay bone fusion gel called Renovite BMP-2. This injectable and moldable gel is designed to retain bone morphogenetic protein-2 (BMP-2) at the surgical site, promoting efficient bone healing while reducing risks such as ectopic bone formation and soft tissue complications that are common with older carriers. This advancement offers a more controlled and effective fusion process.
Key Players Shaping the Orthobiologics Devices and Equipment Market
The competitive landscape includes a number of influential companies such as BONESUPPORT AB, Medtronic plc, Kuros Biosciences Ltd., Stryker Corporation, Baxter International Inc., DePuy Synthes, Braun Melsungen AG, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Arthrex Inc., Enovis Corp., Integra Lifesciences Holding Corporation, NuVasive Inc., Globus Medical Inc., Bioventus LLC, Orthofix Medical Inc., SeaSpine Holdings Corporation, Xtant Medical Holdings Inc., Acumed LLC, and Bone Biologics Corp.
Geographical Breakdown and Market Expansion Trends
In 2025, North America dominated the orthobiologics devices and equipment market as the largest regional segment. Western Europe followed as the second largest. The market report also covers other key regions, including Asia-Pacific, South East Asia, Eastern Europe, South America, the Middle East, and Africa, providing a broad perspective on global demand patterns and growth opportunities.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
